Compound Profile: Beligas Pharma Anavar 50
Beligas Pharma Anavar 50 is a pharmaceutical-grade oxandrolone formulation designed for comprehensive in-vitro research into androgenic receptor interactions. This meticulously manufactured compound enables researchers to investigate the unique anabolic properties of oxandrolone, a synthetic anabolic-androgenic steroid derived from dihydrotestosterone. Each tablet contains precisely measured active compound concentrations, facilitating reproducible experimental protocols in cellular biology studies. Researchers examining protein synthesis pathways, muscle tissue metabolism, and androgenic receptor selectivity will find this formulation invaluable for their laboratory investigations.
Laboratory professionals studying steroid biochemistry can examine oxandrolone’s distinctive molecular structure and its interactions with androgen receptors across various tissue types. The compound’s reduced androgenic activity relative to its anabolic effects makes it particularly interesting for research into selective tissue targeting mechanisms. Scientists at Stroid UK Shop laboratories have access to comprehensive analytical data supporting their research objectives.
Laboratory Applications
Research applications for this oxandrolone formulation span multiple areas of biochemical investigation. Cellular biology researchers examine its effects on nitrogen retention mechanisms in muscle cell cultures, while endocrinology studies focus on its minimal impact on natural testosterone production compared to other anabolic compounds. The pharmaceutical-grade purity enables precise dosimetric studies investigating receptor binding affinity and tissue selectivity patterns. Comparative analyses with other compounds from our Anavar oral steroids collection provide valuable insights into structure-activity relationships.
Metabolic research teams investigate oxandrolone’s unique characteristics in lipid metabolism studies, particularly its documented effects on reducing visceral adipose tissue in research models. Cross-referencing studies with SARM compounds and peptide formulations enable comprehensive comparative analyses of different androgenic pathway modulators.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Oxandrolone |
| Concentration | 50mg per tablet |
| Quantity | 50 tablets |
| Manufacturer | Beligas Pharmaceuticals |
| CAS Number | 53-39-4 |
| Molecular Formula | C₁₉H₃₀O₃ |
| Molecular Weight | 306.44 g/mol |
| Storage Requirements | Room temperature, dry environment |
Research Compliance
This Beligas Pharma Anavar 50 formulation is manufactured exclusively for in-vitro laboratory research applications. Researchers must maintain appropriate laboratory safety protocols and documentation standards throughout their investigations. The compound requires proper storage conditions and handling procedures consistent with laboratory-grade research chemicals. This product is not intended for human consumption, therapeutic applications, or any use outside controlled laboratory environments. All research activities must comply with applicable institutional review boards and regulatory guidelines governing laboratory research with androgenic compounds.
